Benefit from the inclusion of surgery in the treatment of patients with stage III pancreatic cancer: a propensity-adjusted, population-based SEER analysis

References

• SiegelRLMillerKDJemalACancer statistics, 2018CA Cancer J Clin201868173029313949
   PubMed Web of Science ®Google Scholar
• HidalgoMPancreatic cancerN Engl J Med2010362171605161720427809
   PubMed Web of Science ®Google Scholar
• MalvezziMCarioliGBertuccioPEuropean cancer mortality predictions for the year 2017, with focus on lung cancerAnn Oncol20172851117112328327906
   PubMed Web of Science ®Google Scholar
• TemperoMAMalafaMPAl-HawaryMPancreatic adenocarcinoma, version 2.2017, NCCN clinical practice guidelines in oncologyJ Natl Compr Cancer Netw201715810281061
   PubMed Web of Science ®Google Scholar
• YounanGTsaiSEvansDBChristiansKKTechniques of vascular resection and reconstruction in pancreatic cancerSurg Clin North Am20169661351137027865282
   PubMed Web of Science ®Google Scholar
• Von HoffDDErvinTArenaFPIncreased survival in pancreatic cancer with nab-paclitaxel plus gemcitabineN Engl J Med2013369181691170324131140
   PubMed Web of Science ®Google Scholar
• DeneckeTAndreouAPodrabskyPDistal pancreatectomy with en bloc resection of the celiac trunk for extended pancreatic tumor disease: an interdisciplinary approachCardiovasc Intervent Radiol20113451058106420936285
   PubMed Web of Science ®Google Scholar
• KondoSKatohHHiranoSResults of radical distal pan-createctomy with en bloc resection of the celiac artery for locally advanced cancer of the pancreatic bodyLangenbecks Arch Surg2003388210110612684805
   PubMed Web of Science ®Google Scholar
• KlompmakerSde RooijTKortewegJJSystematic review of outcomes after distal pancreatectomy with coeliac axis resection for locally advanced pancreatic cancerBr J Surg2016103894194927304847
   PubMed Web of Science ®Google Scholar
• OcuinLMMiller-OcuinJLNovakSMRobotic and open distal pancreatectomy with celiac axis resection for locally advanced pancreatic body tumors: a single institutional assessment of perioperative outcomes and survivalHPB (Oxford)2016181083584227506992
   PubMed Web of Science ®Google Scholar
• AminMBGreeneFLEdgeSBThe eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer stagingCA Cancer J Clin2017672939928094848
   PubMed Web of Science ®Google Scholar
• AustinPCAn Introduction to propensity score methods for reducing the effects of confounding in observational studiesMultivariate Behav Res201146339942421818162
   PubMed Web of Science ®Google Scholar
• AustinPCThe performance of different propensity score methods for estimating marginal hazard ratiosStat Med201332162837284923239115
   PubMed Web of Science ®Google Scholar
• TsaiSEvansDBTherapeutic advances in localized pancreatic cancerJAMA Surg2016151986286827276001
   PubMed Web of Science ®Google Scholar
• ChristiansKKTsaiSMahmoudANeoadjuvant FOLFIRINOX for borderline resectable pancreas cancer: a new treatment paradigm?Oncologist201419326627424569947
   PubMed Web of Science ®Google Scholar
• WarshawALFernandez-del CastilloCPancreatic carcinomaN Engl J Med199232674554651732772
   PubMed Web of Science ®Google Scholar
• BurrisHA3rdMooreMJAndersenJImprovements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trialJ Clin Oncol1997156240324139196156
   PubMed Web of Science ®Google Scholar
• MooreMJGoldsteinDHammJErlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials GroupJ Clin Oncol200725151960196617452677
   PubMed Web of Science ®Google Scholar
• KleeffJFriessHBuchlerMWNeoadjuvant therapy for pancreatic cancerBr J Surg200794326126217315287
   PubMed Web of Science ®Google Scholar
• FarisJEBlaszkowskyLSMcDermottSFOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts General Hospital Cancer Center experienceOncologist201318554354823657686
   PubMed Web of Science ®Google Scholar
• BooneBASteveJKrasinskasAMOutcomes with FOLFIRINOX for borderline resectable and locally unresectable pancreatic cancerJ Surg Oncol2013108423624123955427
   PubMed Web of Science ®Google Scholar
• ShermanWHChuKChabotJNeoadjuvant gemcitabine, docetaxel, and capecitabine followed by gemcitabine and capecitabine/radiation therapy and surgery in locally advanced, unresectable pancreatic adenocarcinomaCancer2015121567368025492104
   PubMed Web of Science ®Google Scholar
• KatzMHShiQAhmadSAPreoperative modified FOLFIRINOX treatment followed by capecitabine-based chemoradiation for borderline resectable pancreatic cancer: alliance for clinical trials in oncology trial A021101JAMA Surg20161518e16113727275632
   PubMed Web of Science ®Google Scholar
• SukerMBeumerBRSadotEFOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysisLancet Oncol201617680181027160474
   PubMed Web of Science ®Google Scholar
• AndriulliAFestaVBotteriENeoadjuvant/preoperative gemcitabine for patients with localized pancreatic cancer: a meta-analysis of prospective studiesAnn Surg Oncol20121951644166222012027
   PubMed Web of Science ®Google Scholar
• YuXZLiJFuDLBenefit from synchronous portal-superior mesenteric vein resection during pancreaticoduodenectomy for cancer: a meta-analysisEur J Surg Oncol201440437137824560302
   PubMed Web of Science ®Google Scholar
• ZhouYZhangZLiuYLiBXuDPancreatectomy combined with superior mesenteric vein-portal vein resection for pancreatic cancer: a meta-analysisWorld J Surg201236488489122350478
   PubMed Web of Science ®Google Scholar
• GiovinazzoFTurriGKatzMHHeatonNAhmedIMeta-analysis of benefits of portal-superior mesenteric vein resection in pancreatic resection for ductal adenocarcinomaBr J Surg2016103317919126663252
   PubMed Web of Science ®Google Scholar
• SadotEDoussotAO’ReillyEMFOLFIRINOX induction therapy for stage 3 pancreatic adenocarcinomaAnn Surg Oncol201522113512352126065868
   PubMed Web of Science ®Google Scholar
• DholakiaASHacker-PrietzAWildATResection of borderline resectable pancreatic cancer after neoadjuvant chemoradiation does not depend on improved radiographic appearance of tumor-vessel relationshipsJ Radiat Oncol20132441342525755849
   PubMedGoogle Scholar
• MollbergNRahbariNNKochMArterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysisAnn Surg2011254688289322064622
   PubMed Web of Science ®Google Scholar
• GurusamyKSKumarSDavidsonBRFusaiGResection versus other treatments for locally advanced pancreatic cancerCochrane Database Syst Rev20142CD010244
   Google Scholar
• NakamuraTHiranoSNojiTDistal pancreatectomy with en Bloc Celiac axis resection (Modified Appleby Procedure) for locally advanced pancreatic body cancer: a single-center review of 80 consecutive patientsAnn Surg Oncol201623Suppl 596997527495282
   PubMedGoogle Scholar
• BeaneJDHouseMGPittSCDistal pancreatectomy with celiac axis resection: what are the added risks?HPB (Oxford)201517977778426201994
   PubMed Web of Science ®Google Scholar
• AmanoHMiuraFToyotaNIs pancreatectomy with arterial reconstruction a safe and useful procedure for locally advanced pancreatic cancer?J Hepatobiliary Pancreat Surg200916685085719844653
   PubMedGoogle Scholar
• OrcuttSKisBMalafaMCase report: irreversible electroporation for locally advanced pancreatic cancerInt J Surg Case Rep201740545728941969
   PubMedGoogle Scholar
• LinMLiangSWangXPercutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatmentJ Cancer Res Clin Oncol2017143122607261828871458
   PubMed Web of Science ®Google Scholar
• MoirJWhiteSAFrenchJJLittlerPManasDMSystematic review of irreversible electroporation in the treatment of advanced pancreatic cancerEur J Surg Oncol201440121598160425307210
   PubMed Web of Science ®Google Scholar
• MartinRC2ndMcFarlandKEllisSVelanovichVIrreversible electroporation in locally advanced pancreatic cancer: potential improved overall survivalAnn Surg Oncol201320Suppl 3S443S44923128941
   PubMed Web of Science ®Google Scholar
• AnsariDKristofferssonSAnderssonRBergenfeldtMThe role of irreversible electroporation (IRE) for locally advanced pancreatic cancer: a systematic review of safety and efficacyScand J Gastroenterol201752111165117128687047
   PubMed Web of Science ®Google Scholar